CN103110816B - Chinese herba preparation for treating chronic ulcerative colitis - Google Patents
Chinese herba preparation for treating chronic ulcerative colitis Download PDFInfo
- Publication number
- CN103110816B CN103110816B CN201310048170.2A CN201310048170A CN103110816B CN 103110816 B CN103110816 B CN 103110816B CN 201310048170 A CN201310048170 A CN 201310048170A CN 103110816 B CN103110816 B CN 103110816B
- Authority
- CN
- China
- Prior art keywords
- herba
- ulcerative colitis
- rhizoma
- chronic ulcerative
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese herba preparation for treating chronic ulcerative colitis. In the traditional Chinese medicine, the chronic ulcerative colitis is categorized as dysentery, diarrhea and intestinal afflux, and caused by dysfunction of the spleen in transport, internal hot and humid condition, large intestine hot-damp accumulation, intestial injury and sepsis syndrome due to eating disorder and emotional disorder and overwork. In order to solve the problems, the Chinese herba preparation is decocted into decoction in preparation department by adopting the following traditional Chinese materials: white flower cacalia seed, sedum sarmentosum, abutilon fiber, manyleaf meadowure rhizome and root, salvia chinensis, mock-strawberry, verbena, tropaeolum, potentilla cryptotaeniae, humifuse euphorbia herb, campsis grandiflora, panax japonicas, folium callicarpae pedunculatae, white atractylodes rhizome, rhizoma polygonati, arillus longan and liquorice. According to the clinical test, the total effective rate is 95.6%, and the recovery rate and colonoscopy results before and after the treatment are remarkably better than those of the control group.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, relate in particular to a kind of Chinese medicine preparation for the treatment of chronic ulcerative colitis.
Background technology
Chronic ulcerative colitis claims again inflammatory enteritis, is a kind of agnogenic rectum and colon disease, belongs to the difficult diseases of digestive system, and normal easily recurrence, and has dependency with colon cancer morbidity; At present clinically adopt aminosalicylic acids and the solid acids Drug therapy of cortex class more, but there is bounce-back after drug withdrawal, the shortcoming such as curative effect is unstable, long-term prescription side effect is larger.The author proves through clinical trial for many years, adopts rational Treated with Chinese Decoction chronic ulcerative colitis to have good effect, and stable curative effect, the advantage that side effect is little.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine preparation for the treatment of chronic ulcerative colitis.The categories such as primary disease belongs to Chinese medicine dysentery, has loose bowels, morbid state, sick position is at spleen, stomach, large intestine, the cause of disease be diet, disorder of emotion, overworked, cause dysfunction of the spleen in transportation, damp and hot interior life, pents up large intestine, damage intestinal, the rotten blood of meat loses and causes a disease.
The object of the invention is to be achieved through the following technical solutions, the Chinese medicine preparation of this treatment chronic ulcerative colitis is made by the Chinese medicine of following weight portion: Semen Caesalpiniae Minacis 2-7 part, Herba Sedi 3-9 part, Semen Abutili 3-5 part, Radix et Rhizoma Thalictri 5-9 part, Herba Salviae Chinensis 2.5-7.5 part, Herba Duchesneae Indicae 3-8 part, Herba Verbenae 5-10 part, Flos Trollii 4-7 part, Herba Agrimoniae Herba Potentillae Chinensis 3-5 part, Herba Euphorbiae Humifusae 2-6 part, Flos Campsis 1-3 part, Rhizoma Panacis Japonici 1.5-6.5 part, Folium Callicarpae Formosanae 3-6 part, Rhizoma Atractylodis Macrocephalae 5-15 part, Rhizoma Polygonati 10-20 part, Arillus Longan 5-9 part, Radix Glycyrrhizae 3-5 part.
Preferably, 5 parts of Semen Caesalpiniae Minaciss, 6 parts of Herba Sedis, 4 parts of Semen Abutilis, 7 parts of Radix et Rhizoma Thalictri, 4.5 parts of Herba Salviae Chinensiss, 6 parts of Herba Duchesneae Indicaes, 8 parts of Herba Verbenae, 5 parts of Flos Trolliis, 4 parts of Herba Agrimoniae Herba Potentillae Chinensis, 5 parts of Herba Euphorbiae Humifusaes, 2 parts of Flos Campsiss, 3.5 parts of Rhizoma Panacis Japonicis, 4 parts of Folium Callicarpae Formosanaes, 10 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Rhizoma Polygonatis, 7 parts of Arillus Longans, 4 parts, Radix Glycyrrhizae.
Preparation method is by traditional preparation method, and decocting is made decoction.
In side: Semen Caesalpiniae Minacis, Herba Salviae Chinensis, Herba Duchesneae Indicae, Flos Trollii clearing away heat and eliminating dampness, dissipating blood stasis for subsidence of swelling, regulating QI to relieve pain; Herba Sedi, Semen Abutili, Radix et Rhizoma Thalictri eliminating damp-heat, removing toxic substances; Herba Agrimoniae Herba Potentillae Chinensis, Herba Euphorbiae Humifusae, Folium Callicarpae Formosanae promoting blood circulation and hemostasis, removing toxic substances sore; Herba Verbenae, Flos Campsis dissipating blood stasis to promote menstruationg, cooling blood, expelling wind, inducing diuresis to remove edema; The Rhizoma Atractylodis Macrocephalae, Rhizoma Polygonati air making-up and spleen enlivening, nourishing kidney lung moistening, dampness diuretic; Rhizoma Panacis Japonici strengthening by means of tonics, eliminating stasis to stop pain; Arillus Longan invigorating the heart and spleen, nourishing blood to tranquillize the mind; The invigorating middle warmer of Radix Glycyrrhizae QI invigorating, heat-clearing and toxic substances removing, alleviates pain relieving.
Clinical data
1, this group of physical data case is this Out-patient Department and inpatient, selects light, moderate, severe, and patient's 92 examples, are divided into treatment group and matched group at random, treatment group 46 examples, male 26 examples wherein, female's 20 examples; 20~65 years old age, average 45.8 ± 3.5 years old; The course of disease 5~56 months, average 21.5 ± 2.5 months; 14 examples that the state of an illness is slight, moderate 23 examples, severe 9 examples, it is main 32 examples that mucosa infection be take sigmoid colon and rectum, accumulative total left side colon 14 examples.Matched group 46 examples, male 25 examples, female's 21 examples; 21~66 years old age, average 46.0 ± 3.4 years old; The course of disease 6~55 months, average 20.5 ± 2.7 months; 15 examples that the state of an illness is slight, moderate 24 examples, severe 7 examples, it is main 31 examples that mucosa infection be take sigmoid colon and rectum, accumulative total left side colon 15 examples, the inspection of two groups of excrement and the antibacterial culturing body that all do not find the cause of disease, patient age, the course of disease, state of an illness comparing difference not statistically significant (P>0.05), two groups have comparability.
2, diagnostic criteria is with reference to the up-to-date domestic and international Disease Diagnosis Standard > > of < <: all have diarrhoea in various degree, every day 2-10 time is not etc., the aobvious mucosanguineous feces of stool or rare watery stool, companion's stomachache, abdominal distention, borborygmus, weak, poor appetite etc.Stool checks visible pus cell or erythrocyte, the visible mucous hyperemia of fibercolonscopy, edema, hemorrhage, and have a plurality of ulcer that size and form is different, be coated with HUANGBAI(sic) or blood effusion.
3, Therapeutic Method treatment group is taken Chinese medicine preparation of the present invention, prescription is: Semen Caesalpiniae Minacis 5g, Herba Sedi 6g, Semen Abutili 4g, Radix et Rhizoma Thalictri 7g, Herba Salviae Chinensis 4.5g, Herba Duchesneae Indicae 6g, Herba Verbenae 8g, Flos Trollii 5g, Herba Agrimoniae Herba Potentillae Chinensis 4g, Herba Euphorbiae Humifusae 5g, Flos Campsis 2g, Rhizoma Panacis Japonici 3.5g, Folium Callicarpae Formosanae 4g, Rhizoma Atractylodis Macrocephalae 10g, Rhizoma Polygonati 15g, Arillus Longan 7g, Radix Glycyrrhizae 4g, decocting is made decoction, every day, potion, divided morning, 2 sub-services in evening; The oral sulfasalazine sheet of matched group, adult 3 grams of every days, minute takes for 3 times; Two groups equal 3 weeks is a course for the treatment of.
4, criterion of therapeutical effect is with reference to the up-to-date domestic and international disease treatment standard > > of < <: Short Term Clinical is cured: transference cure, fiber colon check mucosa is normal, drug withdrawal or only use maintenance dose medicine, observes 6 months without recurrence; Effective: clinical symptoms disappears substantially, fibro-colonoscope check has mild inflammation reaction and the false meat of part to form; Invalid: after treatment, clinical symptoms and endoscopy are without improvement.
5,3 weeks rear Clinical efficacy comparisons of (1) two group for the treatment of of therapeutic outcome are in Table 1.
Table 1 liang group Clinical efficacy comparison
With matched group comparison, * P<0.05
Treatment group total effective rate is 95.6%, and matched group total effective rate is 80.43%, and treatment group total effective rate, cure rate are obviously better than matched group, two groups of comparisons, and difference has significant (P<0.05).
Before and after (2) two groups of treatments, colonoscopy result is relatively in Table 2.Two groups of comparisons for the treatment of postcolon microscopy result, difference has significant (P<0.05).
Colonoscope result comparison before and after table 2 liang group treatment
With comparison after treatment of control group, * P<0.05
The specific embodiment
Embodiment mono-: take Semen Caesalpiniae Minacis 5g, Herba Sedi 6g, Semen Abutili 4g, Radix et Rhizoma Thalictri 7g, Herba Salviae Chinensis 4.5g, Herba Duchesneae Indicae 6g, Herba Verbenae 8g, Flos Trollii 5g, Herba Agrimoniae Herba Potentillae Chinensis 4g, Herba Euphorbiae Humifusae 5g, Flos Campsis 2g, Rhizoma Panacis Japonici 3.5g, Folium Callicarpae Formosanae 4g, Rhizoma Atractylodis Macrocephalae 10g, Rhizoma Polygonati 15g, Arillus Longan 7g, Radix Glycyrrhizae 4g, decocting is made decoction.
Embodiment bis-: take Semen Caesalpiniae Minacis 2g, Herba Sedi 9g, Semen Abutili 3g, Radix et Rhizoma Thalictri 5g, Herba Salviae Chinensis 7.5g, Herba Duchesneae Indicae 3g, Herba Verbenae 10g, Flos Trollii 4g, Herba Agrimoniae Herba Potentillae Chinensis 5g, Herba Euphorbiae Humifusae 2g, Flos Campsis 3g, Rhizoma Panacis Japonici 1.5g, Folium Callicarpae Formosanae 6g, Rhizoma Atractylodis Macrocephalae 5g, Rhizoma Polygonati 20g, Arillus Longan 5g, Radix Glycyrrhizae 3g, decocting is made decoction.
Embodiment tri-: take Semen Caesalpiniae Minacis 7g, Herba Sedi 3g, Semen Abutili 5g, Radix et Rhizoma Thalictri 9g, Herba Salviae Chinensis 2.5g, Herba Duchesneae Indicae 8g, Herba Verbenae 5g, Flos Trollii 7g, Herba Agrimoniae Herba Potentillae Chinensis 3g, Herba Euphorbiae Humifusae 6g, Flos Campsis 1g, Rhizoma Panacis Japonici 6.5g, Folium Callicarpae Formosanae 3g, Rhizoma Atractylodis Macrocephalae 15g, Rhizoma Polygonati 10g, Arillus Longan 9g, Radix Glycyrrhizae 5g, decocting is made decoction.
Claims (1)
1. treat a Chinese medicine preparation for chronic ulcerative colitis, it is characterized in that this Chinese medicine preparation made by the Chinese medicine of following weight: Semen Caesalpiniae Minacis 5g, Herba Sedi 6g, Semen Abutili 4g, Radix et Rhizoma Thalictri 7g, Herba Salviae Chinensis 4.5g, Herba Duchesneae Indicae 6g, Herba Verbenae 8g, Flos Trollii 5g, Herba Agrimoniae Herba Potentillae Chinensis 4g, Herba Euphorbiae Humifusae 5g, Flos Campsis 2g, Rhizoma Panacis Japonici 3.5g, Folium Callicarpae Formosanae 4g, Rhizoma Atractylodis Macrocephalae 10g, Rhizoma Polygonati 15g, Arillus Longan 7g, Radix Glycyrrhizae 4g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310048170.2A CN103110816B (en) | 2013-01-24 | 2013-01-24 | Chinese herba preparation for treating chronic ulcerative colitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310048170.2A CN103110816B (en) | 2013-01-24 | 2013-01-24 | Chinese herba preparation for treating chronic ulcerative colitis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103110816A CN103110816A (en) | 2013-05-22 |
CN103110816B true CN103110816B (en) | 2014-10-22 |
Family
ID=48409223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310048170.2A Expired - Fee Related CN103110816B (en) | 2013-01-24 | 2013-01-24 | Chinese herba preparation for treating chronic ulcerative colitis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103110816B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103720877B (en) * | 2013-12-22 | 2016-04-13 | 岳爱霞 | A kind of Chinese medicine preparation for the treatment of chronic ulcerative colitis |
CN103705692B (en) * | 2014-01-11 | 2016-01-27 | 李克波 | A kind of Chinese medicine preparation for the treatment of acute gastroenteritis |
CN104771409B (en) * | 2014-01-15 | 2019-02-26 | 上海中医药大学 | The purposes of orientoside |
CN105535498A (en) * | 2016-01-19 | 2016-05-04 | 吕娜娜 | Traditional Chinese medicine preparation for treating chronic ulcerative colitis |
CN105998264A (en) * | 2016-06-19 | 2016-10-12 | 练燕华 | Traditional Chinese medicine for treating chronic ulcerative colitis |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102309701A (en) * | 2010-07-01 | 2012-01-11 | 李静 | Traditional Chinese medicine (TCM) prescription for treating ulcerative colitis |
CN102631652A (en) * | 2012-04-02 | 2012-08-15 | 薛玉青 | Preparation method for traditional Chinese medicine for treating spleen deficiency type colitis |
CN102641488A (en) * | 2012-04-02 | 2012-08-22 | 单淑香 | Preparation method of traditional Chinese medicine for treating spontaneous-perspiration-type colonitis |
-
2013
- 2013-01-24 CN CN201310048170.2A patent/CN103110816B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102309701A (en) * | 2010-07-01 | 2012-01-11 | 李静 | Traditional Chinese medicine (TCM) prescription for treating ulcerative colitis |
CN102631652A (en) * | 2012-04-02 | 2012-08-15 | 薛玉青 | Preparation method for traditional Chinese medicine for treating spleen deficiency type colitis |
CN102641488A (en) * | 2012-04-02 | 2012-08-22 | 单淑香 | Preparation method of traditional Chinese medicine for treating spontaneous-perspiration-type colonitis |
Non-Patent Citations (6)
Title |
---|
健脾化瘀方治疗溃疡性结肠炎32例临床研究;韩涛 等;《新中医》;20090228;第41卷(第02期);45-46 * |
溃疡性结肠炎的中药治疗研究进展;穆丽萍 等;《辽宁中医药大学学报》;20100630;第12卷(第06期);276-278 * |
溃疡性结肠炎的辨证施治;赵时雨;《中原医刊》;19851231(第02期);28-30 * |
穆丽萍 等.溃疡性结肠炎的中药治疗研究进展.《辽宁中医药大学学报》.2010,第12卷(第06期),276-278. |
赵时雨.溃疡性结肠炎的辨证施治.《中原医刊》.1985,(第02期),28-30. |
韩涛 等.健脾化瘀方治疗溃疡性结肠炎32例临床研究.《新中医》.2009,第41卷(第02期),45-46. |
Also Published As
Publication number | Publication date |
---|---|
CN103110816A (en) | 2013-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102362947B (en) | Chinese medicine for treating cough | |
CN103110844B (en) | Traditional Chinese medicine for treating acute tonsillitis | |
CN100542596C (en) | A kind of medicine for the treatment of chronic gastritis, peptic ulcer | |
CN103110816B (en) | Chinese herba preparation for treating chronic ulcerative colitis | |
CN101700358A (en) | Medicine for treating acute and chronic nonspecific ulcerative colitis and preparation method thereof | |
CN102727758B (en) | Traditional Chinese medicine enema for treating ulcerative colitis | |
CN100364594C (en) | Medicine for treating chronic superficial gastritis and peptic ulcer diseases | |
CN103182059B (en) | Traditional Chinese medicine composition for treating chronic gastritis, and application thereof | |
CN104162129A (en) | Traditional Chinese medicine for treating diabetic gastroparesis | |
CN103830714A (en) | Traditional Chinese medicine for treating diarrhoea | |
CN102698189B (en) | Chinese medicinal composition and preparation with function of treating helicobacter pylori in stomach and preparation method thereof | |
CN103893457A (en) | Traditional Chinese medicine for treating ulcerative colitis | |
CN102988559B (en) | Chinese medicinal enema for treating ulcerative colitis | |
CN101804149B (en) | Traditional Chinese medicine for treating faucitis | |
CN102188643B (en) | Medicament for treating damp-heat blockage syndrome and its preparation method | |
CN101502597B (en) | Medicament for treating stomachache and preparation method thereof | |
CN104784650A (en) | Pharmaceutical preparation for clinical nursing of gastric ulcer | |
CN103736028A (en) | Traditional Chinese medicine composition for treating oral lichen planus | |
CN102908446A (en) | Traditional Chinese medicine preparation used for controlling severe acute pancreatitis and acute lung injury complications | |
CN103417809A (en) | TCM preparation for treatment of thrush in infants and children | |
CN102727816B (en) | Traditional Chinese medicine composition used for treating ulcerative colitis | |
CN103301398B (en) | A kind of Chinese medicine composition of atrophic gastritis | |
CN102671032B (en) | Traditional Chinese medicine for treating recurrent aphthae | |
CN103142885B (en) | Chinese medicine enema for treating infant enteritis | |
CN102008677B (en) | Traditional Chinese medicine composition for curing epigastric pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141022 Termination date: 20160124 |
|
EXPY | Termination of patent right or utility model |